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Abstract
Background: We investigated the association of cumulative smoking exposure and duration of smoking cessation
with peripheral arterial disease (PAD).
Methods: The study population consisted of 2517 community-dwelling Korean men aged 50 years and older.
Information on smoking characteristics such as smoking status, pack-years of smoking, and years since quitting
smoking was collected using a standardized questionnaire. PAD was defined as an ankle-brachial index (ABI) less
than 0.90 in either leg.
Results: The odds ratio (OR, 95% confidence interval) of PAD was 2.31 (1.20-4.42) for former smokers and 4.30
(2.13-8.66) for current smokers, after adjusting for other cardiovascular risk factors. There was a significant dose-
response relationship between pack-years of smoking and PAD. Compared with those who had never smoked, the
multivariate-adjusted ORs of PAD for smokers of 0.1-20.0, 20.1-40.0, and >40.0 pack-years were 2.15 (1.06-4.38), 2.24
(1.08-4.65), and 2.93 (1.41-6.09), respectively. There was a significant decrease in PAD risk as the years since quitting
smoking increased. The multivariate-adjusted ORs of PAD for 11-20 and ≥21 years smoking cessation were 0.41
(0.19-0.86) and 0.49 (0.24-0.98), compared with current smokers.
Conclusions: Cumulative smoking exposure and duration of smoking cessation were significantly associated with
PAD in middle aged and older Korean men.
Background
Peripheral arterial disease (PAD), one of the major man-
ifestations of generalized atherosclerotic disease, results
from a narrowing of arteries in the lower extremities, as
a result of progressive atherosclerosis [1]. Although
PAD is a marker of coronary and cerebral atherosclero-
tic vascular disease, PAD is a commonly overlooked
condition in primary care settings, because most
patients are asymptomatic. However, people with PAD,
even if asymptomatic, have an increased risk of future
cardiovascular events and related mortality [2-4]. The
ankle-brachial index (ABI),t h er a t i oo fs y s t o l i cb l o o d
pressure in the ankle to that in the arm, is a simple,
reproducible, and non-invasive test to diagnose PAD
and has been used to diagnose and evaluate the severity
of PAD in the lower extremities [5].
Cigarette smoking contributes to the constriction and
damage of arteries and is a potent risk factor for PAD,
by promoting endothelial dysfunction and by altering
lipoprotein metabolism, coagulation, and platelet func-
tion [6]. A number of epidemiological studies have
reported an association between PAD and both current
and former smoking [7-14], though few studies have
examined the cumulative effects of smoking, such as
pack-years exposure, on PAD [15]. Moreover, because
few studies have examined the association between
smoking cessation and PAD [13], it remains undeter-
mined whether the duration of smoking cessation is
inversely associated with PAD in the general population. * Correspondence: mhshinx@paran.com
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ciation of cumulative cigarette smoking exposure with
PAD prevalence among community-dwelling adults aged
50 years and older, and to determine whether the dura-
tion of smoking cessation was inversely associated
with PAD.
Methods
Subjects
The study population consisted of community-dwelling
men and women aged 50 years and older who partici-
pated in the 2007-2009 baseline surveys of the Dong-gu
Study [16]. We used the national resident registration
records to identify potential participants. In total, 26,323
eligible subjects aged 50 years and over who resided in
o n eo ff i v et o w n si nt h eD o n g - g ud i s t r i c to fG w a n g j u
Metropolitan City in South Korea were invited by tele-
phone to participate. Total 6779 subjects were enrolled
and the response rate for this study was 25.8% (21.8%
for men and 29.1% for women). However, only men
were included in the analysis because of the low preva-
lence of smoking in women (1.9% current smokers and
1.8% former smokers). Of the 2644 men, 100 subjects
were excluded from the study because of incomplete
medical histories, lifestyle characteristics, and anthropo-
metric and biochemical measurements. An additional 21
subjects were excluded because of missing information
on the ABI measurements. Six individuals with an ABI
greater than 1.50 were further excluded from the analy-
sis because this indicates poorly compressible leg
arteries and the inability to gauge arterial perfusion
accurately [17,18]. In total, 2517 subjects were included
in the analyses. This study was conducted in accordance
with the Declaration of Helsinki guidelines and the
study protocol was approved by the institutional review
board of Chonnam National University Hospital. Partici-
pants provided written informed consent.
Definition of smoking
Participants were classified based on smoking habit
information collected using a standardized questionnaire
by well-trained research staff. Smoking was classified as
never smokers (smoked <100 cigarettes in their lifetime
and not currently smoking), former smokers (smoked
≥100 cigarettes in their lifetime and currently a non-
smoker), and current smokers (smoked ≥100 cigarettes
in their lifetime and currently a smoker) [10]. Cumula-
tive smoking exposure in former and current smokers
was determined in terms of pack-years by multiplying
the number of years smoked with the average number
of packs per day [15]. Based on pack-years of smoking,
subjects were classified as never smokers (0.0 pack-
years), light smokers (0.1-20.0 pack-years), moderate
smokers (20.1-40.0 pack-years), and heavy smokers
(> 40 pack-years). Based on information on years since
quitting smoking, former smokers were classified as ≤3
years, 4-10 years, 11-20 years, and ≥21 years and com-
pared with current smokers.
ABI measurement and PAD definition
ABI, an indicator of PAD, was measured using an auto-
mated, non-invasive, waveform analysis device (VP-
1000, Colin Co, Komaki, Japan). The subjects were
examined in the supine position after relaxing in the
supine position on a bed for at least 5 min. Cuffs were
wrapped around both the arms and the ankles, and elec-
trocardiogram electrodes were placed at the left sternal
border. ABI was automatically calculated by dividing the
posterior tibial systolic blood pressure by the brachial
systolic pressure measured by the oscillometric method
with cuffs adapted to the extremities. ABI was obtained
for each leg separately, and the average was used as the
mean ABI. PAD, or an abnormal ABI, was defined as an
ABI of lower than 0.90 in either leg [10,19]. The absence
of PAD was defined as an ABI ≥0.90 and ≤1.50 [17,20].
An ABI less than 0.90 shows 95% sensitivity and 99%
specificity for diagnosing PAD, as confirmed by angio-
graphy [21].
Other variables of interest
Information on the demographic characteristics, lifestyle,
medical history, and medication use of each subject
were assessed with a standardized questionnaire admi-
nistered by trained staff. Alcohol consumption (g/day)
was calculated from the average number of alcoholic
beverages consumed. Physical exercise was categorized
as none (0-1 time per week), irregular exercise (2-4
times per week), and regular exercise (5 or more times
per week) [16]. Body mass index was calculated as
weight in kilograms divided by height in meters squared.
Blood pressure was measured after at least 5 min of rest
in the sitting position using a mercury sphygmoman-
ometer. The average of three consecutive readings of
systolic and diastolic blood pressure taken at 1-min
intervals was used in the analysis. After a 12-h overnight
fast, venous blood samples were collected. Serum total
cholesterol, high-density lipoprotein (HDL) cholesterol,
triglycerides, uric acid, and fasting blood glucose levels
were measured using enzymatic methods. Low-density
lipoprotein (LDL) cholesterol was calculated by the Frie-
dewald formula. All samples were analyzed using an
automatic analyzer (Hitachi7 6 0 0 ,H i t a c h iL t d . ,T o k y o ,
Japan).
Statistical analysis
General characteristics of the study population, based on
the presence or absence of PAD, were expressed as
mean ± standard deviation or number (percentage), and
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variables and chi-squared tests for categorical variables.
Analysis of covariance and multiple logistic regression
were used to evaluate the association of smoking char-
acteristics (e.g., smoking status, cumulative smoking
exposure, and duration of smoking cessation) with mean
ABI and PAD, respectively. Mean (standard error) or
odds ratio (95% confidence interval) were calculated in
unadjusted, age-adjusted, and multivariate-adjusted
models adjusting for age, body mass index, systolic
blood pressure, fasting blood glucose, total cholesterol,
HDL cholesterol, uric acid, alcohol consumption, physi-
cal exercise, and use of medications for hypertension,
diabetes, and hyperlipidemia. Multivariate-adjusted mod-
els of cumulative smoking exposure were further
adjusted for current smoking (yes/no), and multivariate-
adjusted models of duration of smoking cessation were
additionally adjusted for pack-years of smoking. The
trend in the association between smoking characteristics
and PAD was determined after considering smoking
categories as ordinal variables. All statistical analyses
were performed using SPSS 15.0 and P values <0.05
were deemed to indicate statistical significance.
Results
A m o n gt h e2 5 1 7m e na g e d5 0y e a r sa n do l d e r
included in the analysis, 103 subjects had PAD (4.1%)
and 2414 subjects were classified as normal (95.9%).
General characteristics of the study population by the
presence of PAD are presented in Table 1. Significant
differences between those with and without PAD were
observed in age, systolic blood pressure, uric acid,
alcohol consumption, total years of smoking, pack-
years of smoking, and the use of antihypertensive and
antidiabetic medications. The mean ABI was 0.868 ±
0.117 in subjects with PAD and 1.147 ± 0.082 in sub-
jects without PAD (P < 0.001).
Of all the subjects, 616 (24.5%) had never smoked, 1298
(51.6%) were former smokers, and 603 (24.0%) were cur-
rent smokers. Mean ABI and OR for PAD by smoking
status are shown in Table 2. Compared to never smoking,
former and current smokers had significantly smaller
mean ABI in the unadjusted, age-adjusted, and multivari-
ate-adjusted models (P < 0.001 in all models). Moreover,
current smokers had significantly smaller mean ABI than
former smokers in all models. Former and current smo-
kers had significantly higher risk for PAD than those who
had never smoked. Compared with never smoking, the
OR (95% CI) for PAD was 2.31 (1.20-4.42) for former
smokers and 4.30 (2.13-8.66) for current smokers in the
multivariate-adjusted model. Furthermore, the risk of
PAD in current smokers was significantly higher than in
former smokers in the multivariate-adjusted model (OR,
1.89; 95% CI, 1.19-3.01).
Table 3 shows the mean ABI and OR for PAD by
cumulative smoking exposure. A significant decrease in
mean ABI with pack-years of smoking was observed in
all models (P-trend <0.001 in all models). Additionally,
compared with never smoking, light, moderate, and
heavy smokers had significantly lower ABI in all models.
Significant increases in PAD risk with pack-years of
smoking were observed in all models (P-trend <0.001,
<0.001, and = 0.008, respectively). In the multivariate-
adjusted model, compared with those who had never
smoked, the OR for PAD was 2.15 (1.06-4.38), 2.24
(1.08-4.65), and 2.93 (1.41-6.09) in light, moderate, and
heavy smokers, respectively.
Table 4 shows the mean ABI and OR for PAD by
years since quitting smoking. A significant dose-
response association was found between years since
quitting smoking and mean ABI in all models (P-trend
<0.001). Former smokers with 11-20 and ≥21 years of
smoking cessation had significantly greater mean ABI
than individuals who had never smoked in all models.
Table 1 General characteristics of the study population
with and without PAD (n = 2517)
Without
PAD
(n = 2414)
With PAD
(n = 103)
P-
value
a
Age, years 65.9 ± 7.9 70.4 ± 7.3 <0.001
Body mass index, kg/m² 23.9 ± 2.8 23.4 ± 3.0 0.118
Systolic blood pressure, mmHg 124.8 ± 16.3 129.6 ± 19.5 0.014
Diastolic blood pressure,
mmHg
75.7 ± 10.5 74.8 ± 10.0 0.403
Antihypertensive medications,
n (%)
813 (33.7) 53 (51.5) <0.001
Fasting blood glucose, mg/dl 113.3 ± 27.2 116.8 ± 33.1 0.205
Antidiabetic medications, n (%) 362 (15.0) 34 (33.0) <0.001
Total cholesterol, mg/dl 187.7 ± 37.7 189.9 ± 38.3 0.567
LDL cholesterol, mg/dl 109.7 ± 35.7 114.0 ± 37.1 0.231
HDL cholesterol, mg/dl 49.3 ± 12.0 47.1 ± 10.0 0.073
Triglycerides, mg/dl
b 143.7 ± 116.5 144.1 ± 96.4 0.977
Lipid-lowering medications,
n (%)
150 (6.2) 6 (5.8) 0.873
Uric acid, mg/dl 5.8 ± 1.4 6.4 ± 1.9 0.001
Alcohol consumption, gram/day 14.8 ± 23.7 10.1 ± 20.0 0.023
Regular exercise, n (%) 492 (20.5) 16 (15.7) 0.239
Age at starting smoking 22.4 ± 5.6 22.9 ± 6.5 0.427
Total years of smoking, years 31.9 ± 13.8 36.8 ± 14.9 0.001
Number of cigarettes per day 17.9 ± 12.0 19.1 ± 12.7 0.356
Pack-years of smoking 21.5 ± 22.2 31.3 ± 29.7 0.001
Mean ankle-brachial index 1.147 ± 0.082 0.868 ±
0.117
<0.001
Data are presented as means ± standard deviation or number (percentage).
PAD, peripheral arterial disease, was defined as an ankle-brachial index lesser
than 0.90 in either leg; LDL, low-density lipoprotein; HDL, high-density
lipoprotein.
aP-value was obtained by Student’s t-test or by chi-square test.
bP-value was obtained after log-transformation.
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ting smoking in all models (P-trend = 0.002, <0.001, and
<0.001, respectively). The risk of PAD in former smo-
kers with 11-20 years and ≥21 years of smoking cessa-
tion was significantly lower than in current smokers in
all models, and the OR was 0.41 (0.19-0.86) and 0.49
(0.24-0.98) in the multivariate-adjusted models,
respectively.
Discussion
This cross-sectional study of community-dwelling Korean
men demonstrated that cumulative smoking exposure was
positively associated with PAD, defined as an ABI <0.90,
and that duration of smoking cessation was inversely asso-
ciated with PAD, independently of conventional cardiovas-
cular risk factors. Although, as in previous studies, current
smokers had a significantly higher risk for PAD than those
Table 2 Mean ankle-brachial index and odds ratio for peripheral arterial disease according to smoking status
Smoking status
Never smokers
(n = 616)
Former smokers
(n = 1298)
Current smokers
(n = 603)
Mean ankle-brachial index
Unadjusted 1.156 (0.004) 1.134 (0.003)*** 1.118 (0.004)***††
Age-adjusted 1.157 (0.004) 1.134 (0.003)*** 1.116 (0.004)***†††
Multivariate-adjusted
a 1.153 (0.004) 1.134 (0.003)*** 1.120 (0.004)***††
Peripheral arterial disease
b
Prevalence, n (%) 12 (1.9) 55 (4.2) 36 (6.0)
Unadjusted OR 1.00 (reference) 2.23 (1.18-4.19)* 3.20 (1.65-6.20)**
Age-adjusted OR 1.00 (reference) 2.31 (1.22-4.35)* 4.29 (2.18-8.43)***
Multivariate-adjusted
a OR 1.00 (reference) 2.31 (1.20-4.42)* 4.30 (2.13-8.66)***
Unadjusted OR - 1.00 (reference) 1.44 (0.93-2.21)
Age-adjusted OR - 1.00 (reference) 1.87 (1.20-2.92)††
Multivariate-adjusted
a OR - 1.00 (reference) 1.89 (1.19-3.01)††
Data are presented as mean (standard error) or odds ratio (95% confidence interval).
aAdjusted for age, body mass index, systolic blood pressure, fasting blood glucose, total cholesterol, HDL cholesterol, uric acid, alcohol consumption, physical
exercise, and use of medications for hypertension, diabetes, and hyperlipidemia.
bDefined as an ankle-brachial index lesser than 0.90 in either leg.
*P < 0.05, **P < 0.01, ***P < 0.01; compared with never smokers.
†P < 0.05, ††P < 0.01, †††P < 0.01; compared with former smokers.
Table 3 Mean ankle-brachial index and odds ratio for peripheral arterial disease according to cumulative smoking
exposure
Never smokers
(n = 616)
Cumulative smoking exposure (pack-years of smoking)
c P-trend
d
Light smokers
[0.1-20.0 pack-years]
(n = 745)
Moderate smokers
[20.1-40.0 pack-years]
(n = 687)
Heavy smokers
[> 40.0 pack-years]
(n = 438)
Mean ankle-brachial index
Unadjusted 1.156 (0.004) 1.138 (0.004)** 1.125 (0.004)*** 1.118 (0.005)*** <0.001
Age-adjusted 1.156 (0.004) 1.138 (0.004)** 1.124 (0.004)*** 1.119 (0.005)*** <0.001
Multivariate-adjusted
a 1.150 (0.004) 1.137 (0.004)* 1.128 (0.004)*** 1.123 (0.005)*** <0.001
Peripheral arterial disease
b
Prevalence, n (%) 12 (1.9) 30 (4.0) 31 (4.5) 30 (6.8)
Unadjusted OR 1.00 (reference) 2.11 (1.07-4.16)* 2.38 (1.21-4.67)* 3.70 (1.87-7.31)*** <0.001
Age-adjusted OR 1.00 (reference) 2.32 (1.17-4.59)* 2.85 (1.44-5.64)** 3.69 (1.86-7.31)*** <0.001
Multivariate-adjusted
a OR 1.00 (reference) 2.15 (1.06-4.38)* 2.24 (1.08-4.65)* 2.93 (1.41-6.09)** 0.008
Data are presented as mean (standard error) or odds ratio (95% confidence interval).
aAdjusted for age, body mass index, systolic blood pressure, fasting blood glucose, total cholesterol, HDL cholesterol, uric acid, alcohol consumption, physical
exercise, use of medications for hypertension, diabetes, and hyperlipidemia, and current smoking (yes/no).
bDefined as an ankle-brachial index lesser than 0.90 in either leg.
cThirty-one smokers were excluded due to lack of information about pack-years of smoking.
dP-trend estimated from analysis of covariance or logistic regression using the categories of cumulative smoking exposure as an ordinal variable.
*P < 0.05, **P < 0.01, ***P < 0.001; compared with never smokers.
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and years since quitting smoking were also identified as
significant risk factors that should be taken into account to
properly evaluate the effect of cigarette smoking on PAD.
The ABI is considered as a surrogate marker of general-
ized atherosclerosis because low ABI levels have been
associated with elevated risk of future coronary heart dis-
ease [3,22], stroke [3,23,24], and a higher risk of all-cause
and cardiovascular mortality [3,25,26]. A recent meta-
analysis found that the predictive value of ABI for cardio-
vascular morbidity and mortality was similar to that of the
traditional Framingham risk factors [27]. Because ABI is
simple, non-invasive, reproducible, and cost-effective [28],
ABI measurement is routinely performed to screen for
asymptomatic PAD patients. ABI is a useful tool for the
prediction of cardiovascular risk because, compared with
carotid intima-media thickness and coronary artery cal-
cium, it can be performed readily in community settings
and in primary care physicians’ offices [28].
Our results are consistent with previous findings that
current smoking is associated with a 1.86 to 5.48-fold
increase in risk of PAD, compared with never having
smoked [7-14]. Some studies have reported that current
smoking is associated with a 1.60 to 2.80-fold increase
in the risk of PAD, compared with never or previously
smoking [29,30]. Additionally, our findings are analo-
gous to previous findings that former smoking is asso-
ciated with a 1.02 to 1.94-fold increased risk of PAD
[7,9-11,14]; however, generally no significant difference
between former and never smoking has been found.
Although various epidemiological studies have
reported an association between smoking status and
PAD, the majority of studies have examined PAD risk
by smoking status, finding that current smoking
increased PAD risk or smoking cessation decreased
PAD risk. However, the simple smoking status classifica-
tion of never, former, and current smoking has been
questioned on the assumption that lifetime heavy smo-
kers who have recently stopped smoking are categorized
as former smokers, whereas smokers who started smok-
ing only a few months ago are categorized as current
smokers. Thus, cumulative smoking exposure, such as
pack-years, should be taken into account to properly
evaluate the association between cigarette smoking and
PAD. Because few studies have investigated the associa-
tion between cumulative smoking exposure and PAD or
between the duration of smoking cessation and PAD,
the dose-response relationship between smoking habits
(e.g., pack-years of smoking and years since quitting
smoking) and PAD is uncertain. The Edinburgh Artery
Study of 1592 adults reported that the adjusted relative
risk of PAD, compared with never smoking, was 1.70
(95% CI, 0.72-3.99) for moderate smokers (≤25 pack-
years) and 2.72 (95% CI, 1.13-6.53) for heavy smokers (>
25 pack-years) [15]. Recently, a cross-sectional study of
1215 Japanese men found that mean ABI correlated
inversely and linearly with pack-years of smoking and
the OR (95% CI) of PAD, compared with never smok-
ing, was 2.8 (0.8-10.2), 2.8 (0.8-10.0), and 4.2 (1.2-14.6)
for <26, 26-45, and ≥45 pack-years, respectively, suggest-
ing a linear trend [13]. In agreement with previous stu-
dies [13,15], we observed a significant increasing trend
between pack-years of smoking and PAD, confirming
that the effect of cumulative smoking exposure on PAD
Table 4 Mean ankle-brachial index and odds ratio for peripheral arterial disease according to duration of smoking
cessation
Current smokers
(n = 603)
Duration of smoking cessation (years since quitting smoking)
c Never smokers
(n = 616)
P-trend
d
≤ 3 years
(n = 185)
4-10 years
(n = 398)
11-20 years
(n = 303)
≥ 21 years
(n = 357)
Mean ankle-brachial index
Unadjusted 1.118 (0.004) 1.127 (0.007) 1.130 (0.005) 1.140 (0.006)** 1.138 (0.005)** 1.156 (0.004)*** <0.001
Age-adjusted 1.116 (0.004) 1.125 (0.007) 1.129 (0.005)* 1.141 (0.006)*** 1.141 (0.005)*** 1.157 (0.004)*** <0.001
Multivariate-adjusted
a 1.123 (0.004) 1.132 (0.008) 1.134 (0.005) 1.139 (0.006)* 1.138 (0.005)* 1.147 (0.005)*** <0.001
Peripheral arterial disease
b
Prevalence, n (%) 36 (6.0) 6 (3.2) 17 (4.3) 10 (3.3) 16 (4.5) 12 (1.9)
Unadjusted OR 1.00 (reference) 0.53 (0.22-1.27) 0.70 (0.39-1.27) 0.54 (0.26-1.10) 0.74 (0.40-1.35) 0.31 (0.16-0.61)** 0.002
Age-adjusted OR 1.00 (reference) 0.49 (0.20-1.19) 0.59 (0.32-1.08) 0.41 (0.20-0.84)* 0.47 (0.25-0.88)* 0.23 (0.12-0.45)** <0.001
Multivariate-adjusted
a OR 1.00 (reference) 0.47 (0.19-1.17) 0.57 (0.30-1.06) 0.41 (0.19-0.86)* 0.49 (0.24-0.98)* 0.25 (0.11-0.55)** <0.001
Data are presented as mean (standard error) or odds ratio (95% confidence interval).
aAdjusted for age, body mass index, systolic blood pressure, fasting blood glucose, total cholesterol, HDL cholesterol, uric acid, alcohol consumption, physical
exercise, use of medications for hypertension, diabetes, and hyperlipidemia, and pack-year of smoking.
bDefined as an ankle-brachial index lesser than 0.90 in either leg.
cFifty-five former smokers were excluded due to lack of information about years since quitting smoking.
dP-trend estimated from analysis of covariance or logistic regression using the categories of years since quitting smoking as an ordinal variable.
*P < 0.05, **P < 0.01, ***P < 0.001; compared with current smokers.
Lee et al. BMC Public Health 2011, 11:94
http://www.biomedcentral.com/1471-2458/11/94
Page 5 of 7was a dose-response relationship. Cui et al. [13] found
that men who had quit smoking 20 or more years ago
had higher mean ABI and lower prevalence of PAD
than current smokers. In our study, the risk of PAD was
significantly lower with smoking cessation of over
11 years than in current smokers, whereas ≤10 years of
smoking cessation was not significantly associated with
PAD risk, suggesting that long-term smoking cessation
is needed to diminish the effects of smoking on PAD.
Study limitations and strengths
There are several limitations to the present study. First,
the cross-sectional nature limits conclusions about the
direction or causality of associations observed in our
study. Additional prospective studies with incident PAD
are needed to confirm our findings. Second, the possible
measurement errors in smoking characteristics due to the
information being self-reported, without measuring biolo-
gical markers, such as serum cotinine, might have attenu-
ated the relationship between cigarette smoking and PAD.
Third, unmeasured confounding variables could have
affected the association of cigarette smoking and smoking
cessation with PAD. Fourth, because information on envir-
onmental tobacco smoke exposure was not collected, the
effect of passive smoking on PAD cannot be accessed.
Nevertheless, this study has several strengths. First, the
main strength is that few studies have investigated the
association between smoking characteristics (including
pack-years of smoking and years since quitting smoking)
and PAD risk. Our more detailed analysis, compared
with previous studies, allowed us to find a significant
association between smoking habits and PAD. Second,
ABI was measured on both the left and right sides, and
the smallest ABI was used in defining PAD. Third, a
large number of community-dwelling older men partici-
pated in this study. Because subclinical atherosclerosis
progresses with age, the present study population (aged
50 years and older) may help detect an association
between smoking habits and PAD.
Conclusions
In summary, a significant dose-response association
between cumulative smoking exposure and PAD preva-
lence was found in a community-dwelling sample of
Korean men. Additionally, there was a significant inverse
association between duration of smoking cessation and
presence of PAD. From a public health perspective,
considering the high prevalence of current smoking in
Korean men, more aggressive tobacco control efforts
could reduce the number of people who develop PAD.
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